PwC MoneyTree™

PwC MoneyTree is the go-to source for Venture Capital firms and high-growth startups.

The PwC MoneyTree website is home to the PwC/CB Insights quarterly MoneyTree Report. It contains historical trend data beginning with 1995, updates on the Venture Capital and high-growth startups ecosystem, and relevant insights from PwC’s emerging company services and venture capital tax, audit and advisory professionals. The PwC/CB Insights MoneyTree Report is the definitive source of information on venture capital investments in emerging companies. This study is a staple of the financial community, entrepreneurs, government policymakers and the business press worldwide.

US MoneyTree Report

During the third quarter of 2018, VC-backed companies based in the United States saw a 17% increase in funding, bringing up the total dollar amount invested to $28B. US private companies raised 6 $500M+ and 55 $100M+ VC rounds, the most of any quarter on record.

Read the Q3 2018 MoneyTree Report

PwC and CB Insights' Healthcare MoneyTree report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.

Read the Healthcare MoneyTree report

Explore the data

Current quarter investment data

View current quarter investment data by Sector, State, Region or Stage of Development.

The MoneyTree Report website only provides aggregate level data.

For company level information, please contact our provider, CB Insights, at info@cbinsights.com.

Explore current quarter data

Historical trend investment data

View detailed results for the most recent quarter and aggregate trend data, beginning with 2002.

The MoneyTree Report website only provides aggregate level data.

For company level information, please contact our provider, CB Insights, at info@cbinsights.com.

Explore historical trend data

This quarter approached quarterly funding records, with $27.5B invested in VC-backed startups and 55 mega-rounds. On the other hand, VC-backed deal volume is down to a level unseen since Q4 of 2012. As early-stage startups wonder if there are adequate funds available, the overall deal volume (1,229) still reflects a healthy startup ecosystem.

Tom Ciccolella PwC's US Venture Capital Leader

{{filterContent.facetedTitle}}

{{filterContent.facetedTitle}}

Contact us

Tom Ciccolella

US Assurance, Partner, PwC US

Tel: +1 (408) 817 5979

David Silverman

National Emerging Company Services Practice Co-Leader, PwC US

Tel: +1 (646) 471 5421

Mark McCaffrey

US Technology, Media and Telecommunications Leader, PwC US

Tel: +1 (408) 817 4199

Danny Wallace

National Emerging Company Services Practice Co-Leader, PwC US

Tel: +1 (408) 817 5030

Greg Vlahos

Partner, US Pharmaceuticals and Life Sciences , PwC US

Tel: +1 (408) 817 5029

Follow us